Alpha Blue Ocean Investment Group

Alpha Blue Ocean is a specialized alternative investment firm that provides flexible financing solutions to publicly listed small and mid-cap companies, with a significant focus on the life sciences and biotechnology sectors. Founded in 2017, the firm utilizes structured investment vehicles such as convertible bonds and equity lines to support companies through clinical development and commercialization phases. ABO has executed numerous transactions across European and global exchanges, partnering with biotech firms to provide the capital necessary for R&D and operational growth. The firm is known for its "PIPE" (Private Investment in Public Equity) strategies, offering an alternative to traditional venture capital or bank financing.